Cargando…
Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms
The occurrence of antituberculosis drug-induced liver injury affects the effectiveness of antituberculosis treatments. Understanding the mechanism and risk factors of such liver injury may improve the outcomes of those patients who received antituberculosis treatments. In this study, 2,255 pulmonary...
Autores principales: | Su, Qiang, Liu, Qiao, Liu, Juan, Fu, Lingyun, Liu, Tao, Liang, Jing, Peng, Hong, Pan, Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810084/ https://www.ncbi.nlm.nih.gov/pubmed/34872459 http://dx.doi.org/10.1080/21655979.2021.2003930 |
Ejemplares similares
-
Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes
por: Su, Qiang, et al.
Publicado: (2021) -
Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011) -
Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity
por: Wang, Yu, et al.
Publicado: (2019) -
GSTM1 and GSTT1 genetic polymorphisms and their association with antituberculosis drug-induced liver injury
por: Chanhom, Noppadol, et al.
Publicado: (2020) -
Diagnosis of Hypersensitivity Induced by Antituberculosis Drugs
por: Wu, Yuqing, et al.
Publicado: (2021)